Two new therapies and rapid tests could reshape drug-resistant gonorrhea care

Drug-resistant Neisseria gonorrhoeae (the bacterium that causes gonorrhea) has become one of the most urgent antimicrobial-resistant threats to public health worldwide. Clinicians expect to be ...

FDA Grants Emergency Authorization for Bundibugyo Ebola Test

The US Food and Drug Administration granted emergency use authorization for a rapid Ebola test that can detect the virus in ...
News-Medical.Net

Beckman Coulter Diagnostics launches fully automated urinalysis system to meet rising testing volumes

Beckman Coulter Diagnostics, a Danaher company and a global leader in clinical diagnostics, today announced the U.S. launch ...

OraSure Technologies Gets Emergency Use Authorization From FDA for New Ebola Test

OraSure Technologies received emergency use authorization from the Food and Drug Administration for a new version of its ebola test. The diagnostic testing company said Tuesday it received the ...

OraSure Receives Emergency Use Authorization for Second Generation Ebola Test

OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has received Emergency Use ...
Mirror Now on MSN

Hyderabad's BITS creates innovative device for rapid kidney testing

BITS Pilani Hyderabad has created a portable IoT device that quickly tests kidney function by analyzing uric acid, urea, and ...
360Dx

OraSure Gets FDA Emergency Use Authorization for Next-Generation Ebola Test

The second generation test can detect the Bundibugyo strain of the virus that currently poses a threat in the Democratic Republic of the Congo and nearby countries.